March 10, 2026

Beam Therapeutics Inc. (BEAM): Investor Outlook on a Biotech with 80% Upside Potential

Beam Therapeutics Inc. (NASDAQ: BEAM) stands out in the biotechnology sector with its robust pipeline of precision genetic medicines, targeting serious diseases through innovative therapies. Founded in 2017 and based..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking the 175% Potential Upside

Investors are taking a keen interest in Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, as it continues to make waves in the biotechnology sector. With a market capitalization..

Privia Health Group, Inc. (PRVA): Analyst Consensus Highlights 36.7% Upside Potential

For investors keen on tapping into the healthcare sector’s burgeoning technology and services segment, Privia Health Group, Inc. (NASDAQ: PRVA) presents a compelling opportunity. The company’s focus on physician enablement..

CG Oncology, Inc. (CGON) Stock Analysis: Unpacking a 31% Potential Upside in Biotech’s Hot Sector

As CG Oncology, Inc. (CGON) continues to make waves in the healthcare sector, particularly within the biotechnology industry, investors are taking a keen interest in its promising pipeline and substantial..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Evaluating a 28% Upside Potential in Biotech

PTC Therapeutics, Inc. (NASDAQ: PTCT) is making waves in the biotechnology sector, offering investors an intriguing opportunity given its current market positioning and growth prospects. With a market cap of..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 12.76% Potential Upside in the Healthcare Sector

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector with a market capitalization of $2.56 billion, operates at the intersection of medical instruments and supplies. This Charlotte-based..

Veracyte, Inc. (VCYT): Investor Outlook Highlights 42% Potential Upside

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector specializing in diagnostics and research, is currently capturing the attention of investors thanks to a promising potential upside of..

Progyny, Inc. (PGNY) Investor Outlook: Exploring a 56.91% Potential Upside in Healthcare Plans

Progyny, Inc. (NASDAQ: PGNY) stands out in the healthcare sector as a prominent player in the niche market of fertility and family-building benefits. For investors seeking a company with significant..

Apellis Pharmaceuticals (APLS) Stock Analysis: Exploring a 68.77% Upside Potential in Biotechnology

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands at the forefront of the biotechnology sector, with a market capitalization of $2.56 billion. Headquartered in Waltham, Massachusetts, this commercial-stage biopharmaceutical company is making..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 50.93% Upside Potential in the Medical Device Sector

UFP Technologies, Inc. (UFPT), a key player in the medical device sector, is drawing significant attention from investors due to its robust market positioning and impressive growth potential. Headquartered in..

Sotera Health Company (SHC) Stock Analysis: A 42% Potential Upside Beckons Investors

Sotera Health Company (NASDAQ: SHC) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $4.14 billion, the company..

Ardent Health, Inc. (ARDT) Stock Analysis: Navigating a 39.77% Potential Upside in the Healthcare Sector

Ardent Health, Inc. (ARDT) is garnering attention within the healthcare sector for its potential upside of nearly 40%, according to recent analyst ratings. Operating in the medical care facilities industry,..

Alvotech (ALVO) Stock Analysis: Is a 368% Upside Within Reach for This Biosimilar Pioneer?

Alvotech (NASDAQ: ALVO) is steadily carving out its niche in the healthcare sector, focusing on the development and manufacturing of biosimilar medicines. With a market capitalization of $1.25 billion, Alvotech..

Scholar Rock Holding Corporation (SRRK): Investor Outlook on a Biotech Innovator with 24.51% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is increasingly becoming a focal point for investors looking to capitalize on the innovative strides being made in the biotechnology sector. With a market..

Immunovant, Inc. (IMVT) Stock Analysis: Potential 55% Upside Sparks Investor Interest

Immunovant, Inc. (NASDAQ: IMVT), a promising player in the biotechnology sector, has captured investor attention with its potential for significant upside. With a market capitalization of $5.38 billion, this clinical-stage..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Gem with 18% Potential Upside

Belite Bio, Inc (NASDAQ: BLTE) stands as a promising prospect in the biotechnology sector, captivating investor interest with its robust clinical pipeline and a potential upside of 18.08% based on..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 62% Upside Potential in the Biotechnology Sector

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology sector, is capturing investor attention with its promising growth prospects and robust market position. With a market capitalization of $1.73..

LivaNova PLC (LIVN): Investor Outlook on Strong Revenue Growth Amidst Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors seeking exposure to innovative medical technology. With..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 30% Potential Upside in Biotechnology

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology firm based in Zug, Switzerland, is making waves in the healthcare sector. Specializing in innovative treatments for inflammatory skin and joint diseases, MoonLake’s..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Healthcare Genomics Leader with 65.77% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS) is capturing investor attention across the healthcare sector with its robust position in the diagnostics and research industry. With a market capitalization of $2.77 billion,..

Search

Funds

March 10, 2026

Search

Funds

March 10, 2026

FTSE 100

Funds